{"id":"https://openalex.org/W4396586733","doi":"https://doi.org/10.1158/1535-7163.mct-23-0520","title":"Bruton Tyrosine Kinase Degraders in B-Cell Malignancies","display_name":"Bruton Tyrosine Kinase Degraders in B-Cell Malignancies","publication_year":2024,"publication_date":"2024-05-02","ids":{"openalex":"https://openalex.org/W4396586733","doi":"https://doi.org/10.1158/1535-7163.mct-23-0520","pmid":"https://pubmed.ncbi.nlm.nih.gov/38693903"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-23-0520","doi":"https://doi.org/10.1158/1535-7163.mct-23-0520","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-23-0520","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Tiana Huynh","orcid":"https://orcid.org/0009-0002-4021-3433","observed_orcids":["https://orcid.org/0009-0002-4021-3433"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tiana Huynh","raw_affiliation_strings":["1City of Hope National Medical Center, Duarte, California"],"raw_orcid":"https://orcid.org/0009-0002-4021-3433","affiliations":[{"raw_affiliation_string":"1City of Hope National Medical Center, Duarte, California","institution_ids":["https://openalex.org/I1301076528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014440924","display_name":"Sonia Rodr\u0131\u0301guez","orcid":"https://orcid.org/0000-0002-5878-9089","observed_orcids":["https://orcid.org/0000-0002-5878-9089"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonia Rodriguez-Rodriguez","raw_affiliation_strings":["1City of Hope National Medical Center, Duarte, California"],"raw_orcid":"https://orcid.org/0009-0008-5474-8598","affiliations":[{"raw_affiliation_string":"1City of Hope National Medical Center, Duarte, California","institution_ids":["https://openalex.org/I1301076528"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067633124","display_name":"Alexey Valeryevich Danilov","orcid":"https://orcid.org/0000-0003-4461-0970","observed_orcids":["https://orcid.org/0000-0003-4461-0970"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexey V. Danilov","raw_affiliation_strings":["1City of Hope National Medical Center, Duarte, California"],"raw_orcid":"https://orcid.org/0000-0003-4461-0970","affiliations":[{"raw_affiliation_string":"1City of Hope National Medical Center, Duarte, California","institution_ids":["https://openalex.org/I1301076528"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1301076528"],"apc_list":null,"apc_paid":null,"fwci":0.3482,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.48307516,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"23","issue":"5","first_page":"619","last_page":"626"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.676800012588501,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.676800012588501,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.2964000105857849,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase","display_name":"Bruton's tyrosine kinase","score":0.9810000061988831},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.8980000019073486},{"id":"https://openalex.org/keywords/b-cell-malignancies","display_name":"B-cell malignancies","score":0.9290000200271606},{"id":"https://openalex.org/keywords/b-cell-receptor-signaling","display_name":"B cell receptor signaling","score":0.8560000061988831},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.8799999952316284},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9160000085830688},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.8209999799728394},{"id":"https://openalex.org/keywords/phosphatidylinositol-4-5-bisphosphate","display_name":"phosphatidylinositol 4,5-bisphosphate","score":0.5230000019073486},{"id":"https://openalex.org/keywords/syk","display_name":"Syk","score":0.7350000143051147},{"id":"https://openalex.org/keywords/plcgamma2","display_name":"PLC\u03b32","score":0.6110000014305115},{"id":"https://openalex.org/keywords/tec-family-kinases","display_name":"Tec family kinases","score":0.6010000109672546},{"id":"https://openalex.org/keywords/chronic-antigen-stimulation","display_name":"chronic antigenic stimulation","score":0.4869999885559082},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.31200000643730164}],"concepts":[{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.6955042481422424},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.6021952629089355},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5040806531906128},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.460134893655777},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2819676995277405},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.10935017466545105}],"mesh":[{"descriptor_ui":"D000077329","descriptor_name":"Agammaglobulinaemia Tyrosine Kinase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000077329","descriptor_name":"Agammaglobulinaemia Tyrosine Kinase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000077329","descriptor_name":"Agammaglobulinaemia Tyrosine Kinase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000077329","descriptor_name":"Agammaglobulinaemia Tyrosine Kinase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000077329","descriptor_name":"Agammaglobulinaemia Tyrosine Kinase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000077329","descriptor_name":"Agammaglobulinaemia Tyrosine Kinase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000077329","descriptor_name":"Agammaglobulinaemia Tyrosine Kinase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000077329","descriptor_name":"Agammaglobulinaemia Tyrosine Kinase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000077329","descriptor_name":"Agammaglobulinaemia Tyrosine Kinase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000077329","descriptor_name":"Agammaglobulinaemia Tyrosine Kinase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015448","descriptor_name":"Leukemia, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D059748","descriptor_name":"Proteolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059748","descriptor_name":"Proteolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059748","descriptor_name":"Proteolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059748","descriptor_name":"Proteolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059748","descriptor_name":"Proteolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-23-0520","doi":"https://doi.org/10.1158/1535-7163.mct-23-0520","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-23-0520","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:38693903","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38693903","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.6240000128746033,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":71,"referenced_works":["https://openalex.org/W1512690422","https://openalex.org/W1628369270","https://openalex.org/W1993345471","https://openalex.org/W1997952190","https://openalex.org/W2007064144","https://openalex.org/W2015345028","https://openalex.org/W2015363069","https://openalex.org/W2028681024","https://openalex.org/W2035135710","https://openalex.org/W2060916625","https://openalex.org/W2066373927","https://openalex.org/W2075875145","https://openalex.org/W2089103836","https://openalex.org/W2095491662","https://openalex.org/W2095500420","https://openalex.org/W2158313081","https://openalex.org/W2227431445","https://openalex.org/W2237195636","https://openalex.org/W2532482854","https://openalex.org/W2589238872","https://openalex.org/W2606935597","https://openalex.org/W2767426216","https://openalex.org/W2767856718","https://openalex.org/W2791299132","https://openalex.org/W2794404663","https://openalex.org/W2805296794","https://openalex.org/W2806694687","https://openalex.org/W2883024539","https://openalex.org/W2887384183","https://openalex.org/W2891134112","https://openalex.org/W2905558559","https://openalex.org/W2917078121","https://openalex.org/W2921689597","https://openalex.org/W2991597369","https://openalex.org/W2994919776","https://openalex.org/W3000715281","https://openalex.org/W3008279882","https://openalex.org/W3012324425","https://openalex.org/W3013296766","https://openalex.org/W3021210206","https://openalex.org/W3047048853","https://openalex.org/W3081170494","https://openalex.org/W3092500411","https://openalex.org/W3128877211","https://openalex.org/W3162999142","https://openalex.org/W3196331199","https://openalex.org/W3214572735","https://openalex.org/W4213416073","https://openalex.org/W4229368832","https://openalex.org/W4280547621","https://openalex.org/W4281654077","https://openalex.org/W4284888202","https://openalex.org/W4295366450","https://openalex.org/W4297499155","https://openalex.org/W4303954706","https://openalex.org/W4307038443","https://openalex.org/W4309028430","https://openalex.org/W4312064763","https://openalex.org/W4364356934","https://openalex.org/W4366496779","https://openalex.org/W4376872367","https://openalex.org/W4383197912","https://openalex.org/W4384700316","https://openalex.org/W4389231314","https://openalex.org/W4389232285","https://openalex.org/W4389234889","https://openalex.org/W4389259210","https://openalex.org/W4391428485","https://openalex.org/W6683097565","https://openalex.org/W6777189155","https://openalex.org/W6784613235"],"related_works":["https://openalex.org/W2746717744","https://openalex.org/W292197667","https://openalex.org/W1963500867","https://openalex.org/W2018466312","https://openalex.org/W3175509069","https://openalex.org/W4200296839","https://openalex.org/W2537142759","https://openalex.org/W2621331090","https://openalex.org/W1807266461","https://openalex.org/W4238550455"],"abstract_inverted_index":{"Bruton":[0],"tyrosine":[1,75,83,100,118],"kinase":[2,84,105,148,394,961,1000,1921],"(BTK)":[3],"belongs":[4],"to":[5,46,92,146,163,167,224,375,381,407,506,524,535,552,558,566,589,615,626,631,682,778,796,835,847,880,909,917,919,959,983,996,1013,1093,1131,1177,1184,1188,1210,1249,1255,1281,1311,1366,1393,1445,1455,1519,1626,1671,1751,1817,1915,2023,2136,2238,2309,2389,2641,2659,3114,3147,3216,3248,3279,3395,3450,3590,3679,3754,3802,3843,3869,3887,3922,3985,3997,4000,4012,4023,4098,4100,4106,4125],"the":[6,36,47,93,161,164,211,220,225,273,280,316,369,402,525,548,553,567,573,576,587,590,599,605,611,616,623,629,632,707,721,746,812,826,836,848,920,927,994,999,1005,1019,1034,1043,1058,1061,1065,1074,1084,1090,1094,1096,1100,1105,1107,1112,1115,1119,1137,1141,1152,1157,1172,1178,1185,1192,1199,1204,1222,1243,1250,1257,1267,1278,1293,1329,1338,1347,1364,1368,1382,1446,1451,1456,1466,1536,1653,1711,1722,1726,1748,1840,1892,1959,2009,2014,2065,2075,2111,2131,2143,2231,2243,2264,2391,2402,2578,2642,2778,2785,2813,2863,2869,3026,3070,3077,3109,3151,3180,3376,3380,3491,3564,3599,3637,3650,3680,3722,3731,3758,3763,3789,3852,3859,3943,3949,3953,3991,4003,4014,4043,4053,4075,4085,4091,4101,4126,4138,4165,4199,4207],"TEC":[7],"family":[8,73],"of":[9,52,65,90,99,110,191,213,219,229,272,291,307,318,368,405,419,446,499,511,517,572,598,608,664,700,711,716,748,774,802,829,838,850,856,929,949,1008,1022,1045,1060,1081,1086,1111,1140,1156,1245,1252,1259,1295,1340,1346,1448,1551,1602,1619,1696,1710,1715,1759,1770,1805,1833,2038,2078,2123,2165,2177,2255,2266,2289,2332,2357,2393,2404,2412,2432,2441,2470,2473,2497,2517,2543,2585,2610,2644,2671,2690,2739,2755,2765,2793,2818,2824,2866,2887,2922,2950,2965,2972,2986,3021,3073,3153,3186,3226,3241,3267,3336,3349,3355,3359,3365,3387,3470,3481,3573,3596,3652,3683,3733,3740,3766,3769,3794,3821,3920,3930,3940,3948,3977,3994,4037,4055,4077,4088,4104,4128,4140,4168],"nonreceptor":[10],"kinases":[11,76],"and":[12,24,50,96,182,204,206,227,247,257,320,350,360,385,443,453,471,530,555,569,650,671,698,723,727,762,781,786,799,810,818,841,875,901,955,1050,1114,1154,1195,1203,1289,1361,1373,1405,1418,1462,1473,1486,1498,1513,1548,1556,1569,1577,1583,1591,1604,1608,1630,1636,1643,1699,1701,1707,1731,1745,1765,1828,1843,1848,1898,1904,1909,1939,1946,1967,1977,2007,2033,2045,2055,2070,2098,2120,2171,2187,2235,2242,2247,2284,2315,2336,2354,2359,2365,2380,2395,2407,2436,2483,2489,2502,2512,2533,2555,2560,2650,2662,2674,2682,2742,2750,2759,2795,2800,2878,2885,2892,2911,2918,2924,2934,2941,2952,2968,2974,2978,2996,2999,3016,3019,3028,3057,3102,3118,3123,3128,3155,3174,3183,3195,3214,3313,3327,3374,3392,3407,3426,3445,3486,3515,3551,3556,3561,3571,3584,3658,3670,3725,3748,3771,3807,3858,3871,3924,3979,4027,4041,4068,4150,4154,4174,4191,4193],"is":[13,176,245,383,386,436,706,1038,1054,1102,1121,1148,1170,1219,3164,3416,3518,3527,3615,3878,3885,3958,3983,4009,4112,4160,4211],"expressed":[14],"in":[15,35,210,239,250,283,310,333,355,387,392,398,411,455,482,648,678,686,720,745,816,819,833,882,1030,1136,1163,1275,1286,1292,1302,1350,1356,1425,1432,1481,1523,1579,1593,1622,1658,1678,1788,1811,1869,1958,1996,2081,2094,2155,2249,2259,2263,2274,2279,2319,2342,2368,2377,2523,2536,2550,2569,2595,2635,2638,2700,2728,2769,2798,2828,2903,2957,2990,3001,3024,3039,3060,3076,3108,3121,3124,3158,3188,3207,3259,3281,3334,3372,3403,3455,3507,3530,3534,3641,3664,3717,3757,3773,3781,3898,3926,3942,3965,3975,4034,4039,4052,4064,4066,4069,4118,4137,4152,4218],"various":[16,734,1330,2188],"hematopoietic":[17],"cells,":[18,21,23,29,232,805,809,1427,2802,2944,2960],"including":[19,199,1083,1321,1918,2146,3851],"B":[20,28,37,54,196,231,804],"myeloid":[22],"platelets":[25],"(1).":[26],"Within":[27],"BTK":[30,91,111,131,150,234,244,308,344,399,408,937,964,979,1322,1386,1396,1424,1433,1522,1552,1655,1688,1716,1736,1787,1857,1908,1934,1984,1994,2079,2241,2261,2270,2310,2317,2353,2363,2420,2521,2535,2592,2636,2661,2716,2744,2788,2829,2838,2947,2992,3014,3251,3298,3418,3462,3521,3618,3638,3743,3770,3779,3826,3894,3969,3973,3995,4020,4089,4105],"plays":[31],"a":[32,115,154,177,189,236,289,338,444,488,496,520,528,531,560,583,595,870,883,887,1031,1079,1160,1227,1233,1514,1544,1597,1614,1760,1780,1849,1859,1874,1895,1923,1931,2036,2116,2156,2181,2217,2223,2287,2293,2299,2366,2410,2423,2439,2454,2467,2495,2509,2537,2541,2581,2619,2633,2656,2663,2669,2753,2791,2904,2915,2919,2930,2935,3002,3006,3083,3165,3224,3238,3282,3346,3353,3370,3412,3417,3456,3519,3531,3692,3738,3915,3927,4078,4120,4134,4161,4212],"critical":[33],"role":[34,238,332,1162],"cell":[38,94,197,259,322,1611,1704,1813,2100,3161],"receptor":[39,3817],"(BCR)":[40],"signaling":[41,192,313,422,971,2692,3262],"pathway,":[42,282,427],"where":[43,417,1933],"it":[44,593,603,635,1053,2565,2881,3957,3982],"contributes":[45,1176],"differentiation,":[48],"proliferation,":[49],"survival":[51,226],"normal":[53],"cells":[55,1483,1525,1585,1595,1660,1790,1807,2083,2097,2321,2433,2525,2684,2820,2874,3023],"(2).BCR":[56],"pathway":[57,222,298],"activation":[58,68,109,129,418,3018,3162],"begins":[59],"when":[60,1815,2340,2463],"antigen":[61,217,3816],"stimulation":[62,218],"induces":[63],"phosphorylation":[64,98,1689,1695],"immunoreceptor":[66],"tyrosine-based":[67],"motifs":[69],"(ITAM)":[70],"by":[71,286,390,742,859,873,985,1042,1104,1217,1226,1954,2110,2577,2627,2632,2894,3149,3253,3265,3274,3277,3730,3831,3914,4115,4206],"SRC":[72],"protein":[74,702,2593,3120],"(e.g.,":[77,3786,3907],"LYN;":[78],"ref.":[79,173,541,581,1822,3199,3541,3612,3718],"2).":[80],"Consequently,":[81,185],"spleen":[82,2265,3029],"(SYK)":[85],"becomes":[86],"activated,":[87],"facilitating":[88],"recruitment":[89],"membrane":[95,166],"subsequent":[97,570],"551":[101],"(Y551)":[102],"within":[103,122,296,1791,2717,2732,3467,3952],"BTK's":[104,123,330,393,987],"domain":[106,125,395],"(2).":[107],"This":[108,973,1146,1169,1324,1929],"prompts":[112],"autophosphorylation":[113],"at":[114,1098,1117,1240,1484,1613,1669,1798,1858,1880,2085,2125,2142,2311,2322,2587,2841,2854,2948,2970,3211],"second":[116],"site,":[117],"223":[119],"(Y223),":[120],"located":[121],"SH3":[124],"(3).":[126],"With":[127],"complete":[128,2729,3250,3466],"achieved,":[130],"can":[132,550,891,912,1353,3911],"then":[133,621],"phosphorylate":[134],"its":[135,147,661],"immediate":[136],"downstream":[137,969],"target,":[138],"phospholipase-C\u03b32":[139],"(PLC\u03b3;":[140],"refs.":[141,262,704,765,1070],"2,":[142],"3).":[143,243],"In":[144,266,301,769,869,907,1398,1802,1872,2445,2698,2939,3005,3139,4016],"addition":[145],"activity,":[149,3425],"also":[151,751,1183,1197,1500,1632,1734,2016,2845],"serves":[152],"as":[153,425,755,953,1002,1004,1150,1221,1690,1692,1861,1863,2230,2296,2298,2324,2326,2398,2400,2422,2508,2685,2687,2831,2833,3079,3082,3263,3797,3811],"scaffold,":[155],"shuttling":[156],"phosphatidylinositol-4-phosphate":[157],"5-kinase":[158],"(PIP5KI)":[159],"from":[160,610,864,1089,1409,2000,4177,4189,4196],"cytosol":[162],"plasma":[165,3268],"produce":[168],"phosphatidylinositol":[169],"(4,":[170],"5)-bisphosphate":[171],"(PIP2;":[172],"4).":[174],"PIP2":[175],"substrate":[178,776],"for":[179,195,636,898,1063,1337,1982,2568,2605,2621,2853,3069,3861,4084,4164],"both":[180,469,784,815,998,1151,1414,1778,1902,1965,1983,2043,2095,2378,2531,2966,3025,3116,3684],"PLC\u03b3":[181],"PIP3":[183],"(4).":[184],"these":[186,327,546,839,950,976,1017,1300,1627,2848,3064,3074],"events":[187,3287,3303,3321,3480,3568,3580,3592],"trigger":[188],"cascade":[190],"pathways":[193],"important":[194,1149],"homeostasis,":[198],"AKT,":[200,1697],"MAPK":[201],"(including":[202],"ERK":[203],"JNK),":[205],"NF-\u03baB":[207,281],"(2,":[208,242,324],"3).However,":[209],"context":[212,1294,4127],"B-cell":[214,270,275,334,484,770,1015,3196,3513,3538,4141,4156],"malignancies,":[215,485,771,4142],"chronic":[216,253],"BCR":[221,457,970,2691,3261],"leads":[223,565],"proliferation":[228,798,2356,3020],"malignant":[230,803],"with":[233,252,288,315,341,413,441,448,451,468,945,1265,1315,1491,1596,1665,1685,1738,1777,1794,1808,1819,1944,2068,2149,2162,2203,2207,2213,2252,2269,2375,2434,2438,2453,2500,2540,2614,2708,2721,2762,2790,2821,2836,2875,3100,3191,3231,3235,3237,3245,3289,3294,3297,3340,3345,3367,3434,3443,3476,3509,3536,3549,3628,3783,3805,3904,3932,4058,4143],"playing":[235],"pivotal":[237],"disease":[240,3391,3853],"pathogenesis":[241],"overexpressed":[246,2341],"constitutively":[248],"phosphorylated":[249],"patients":[251,293,412,440,447,466,943,2001,3099,3190,3228,3230,3234,3339,3366,3388,3406,3442,3508,3535,3548,3899,3931],"lymphocytic":[254],"leukemia":[255],"(CLL)":[256],"mantle":[258],"lymphoma":[260,271,415],"(MCL;":[261],"3,":[263],"5,":[264],"6).":[265],"addition,":[267,1554,1803,1873,2446,3140],"diffuse":[268,3511],"large":[269,3512,3928],"activated":[274],"type":[276],"(ABC-DLBCL)":[277],"relies":[278,1077],"on":[279,1057,1078,1333,2005,3411,3546,3848,3890,3987,4006],"part":[284,388],"driven":[285,389],"BTK,":[287,1009,1575,1891,2405],"majority":[290,3364],"ABC-DLBCL":[292],"harboring":[294],"mutations":[295,391,461,938,2141,3941,3950,4117],"this":[297,1351,1399,1825,2208,2304,3435,3629,3642,3844,3875,3891,3966,3988],"(3,":[299],"7).":[300],"multiple":[302,342,893,3849,3933],"myeloma":[303,3934],"(MM),":[304],"high":[305],"expression":[306,685,1109,2884,3682],"results":[309,454,823,2573,3222],"increased":[311,2450,3159],"AKT":[312],"associated":[314,1314],"upregulation":[317],"stemness":[319],"MM":[321],"self-renewal":[323],"8).":[325],"Collectively,":[326],"observations":[328,3036],"highlight":[329,1328],"oncogenic":[331],"malignancies.BTK":[335],"has":[336,479,657,1887,3142,4049],"become":[337],"well-validated":[339],"target":[340,710,894,913,997,1180,1926,2137,2660,3676],"covalent":[343,470,1371,1385,1541,1727],"inhibitors":[345,3785,3974],"(BTKi's,":[346],"e.g.,":[347],"ibrutinib,":[348,1991,2091],"acalabrutinib,":[349],"zanubrutinib)":[351],"receiving":[352],"regulatory":[353,480],"approvals":[354],"CLL,":[356,3510,3774],"MCL,":[357],"lymphoplasmacytic":[358],"lymphoma,":[359,3514],"marginal":[361],"zone":[362],"lymphoma.":[363],"A":[364,514,1343,2106,3106],"recent":[365,871,2107],"FDA":[366],"approval":[367,481],"noncovalent":[370,472,1495,1534,1649,1753,2419,2931,3413],"BTKi":[371,3414,4129],"pirtobrutinib":[372],"further":[373,2575,2603,3715],"contributed":[374],"field":[376,4054],"evolution":[377],"(9).":[378],"However,":[379,3625,3668],"resistance":[380,406,430,982,3921,3999],"BTKi's":[382,473,946,984],"inevitable,":[384],"(10).":[396],"Mutations":[397],"are":[400,504,674,718,831,878,957,1048,3631,3698,3701],"not":[401,1039,1055,1174,1878,1990,2090,2103,2210,2271,2747,3422,3429,3632,4096,4113],"sole":[403],"explanation":[404],"inhibitors,":[409,910],"particularly":[410],"non-Hodgkin":[414],"(NHL),":[416],"alternative":[420],"prosurvival":[421],"pathways,":[423],"such":[424,754,772,843,952,3796,3810],"PI3K":[426],"underlies":[428],"drug":[429],"(11,":[431],"12).":[432],"Nevertheless,":[433],"BTKC481S":[434,1976,2010,2046,2093,2124,2157,2337,2396,2437,2969,3041,3119],"mutation":[435,1717],"commonly":[437],"observed":[438,1677,1797,1879,2212,2372,2462,3288,3333,3506],"among":[439,465,1836,3375],"CLL":[442,1680,1703,1998,2959,3007,3022,3042,3101,3194,3342,3368,3446,3552,3978,4040,4153],"subset":[445],"MCL":[449,2348,2381,3516],"treated":[450,467,944,2871,3903],"ibrutinib":[452,1410,1886,1905,1925,1968,2006,2695],"constitutive":[456],"signaling,":[458],"whereas":[459,1767,3576],"additional":[460,737,3694,3862],"have":[462,645,750,793,939,993,1937,1949,3088,3094,3674,3963],"been":[463,646,752,794,940,3902,4050],"described":[464,879,2926],"(13\u201316).":[474],"Currently,":[475,639],"no":[476,2163,3879],"therapeutic":[477,1309],"agent":[478,3436,3630],"BTKi-resistant":[483,1014],"thereby":[486,2277,3687],"representing":[487,1283],"strong":[489,4162],"unmet":[490],"medical":[491],"need.Proteolysis-targeting":[492],"chimeras":[493],"(PROTAC)":[494],"represent":[495],"promising":[497],"class":[498],"small":[500,866,1317],"heterobifunctional":[501],"molecules,":[502],"which":[503,564,620,717,1099,1118,1207,1470,1508,1572,1837,2020,2221,2601,2629,2654,2804,2991,3420,3620,3865,3917],"designed":[505],"selectively":[507,2239,2307],"degrade":[508,779,892,2240,3115,3430],"specific":[509,3700],"proteins":[510,665,931],"interest":[512],"(POI).":[513],"PROTAC":[515,549,584,679,889,1287,1429,1542,2108,2234],"consists":[516],"three":[518],"components:":[519],"ligand":[521,532,2658],"that":[522,533,825,975,1047,1127,1231,1389,1438,1465,1502,1539,1640,1900,2197,2564,2580,2781,2816,2847,2880,3051,3093,3526,3649,3697,3884,3960],"binds":[523,534],"POI":[526,554,574,588,1035,1066,1101,1120,1268,1279,1452,1941],"(\u201chook\u201d),":[527],"linker,":[529],"an":[536,1284,1306,1510,1771,1831,1845,2174,2387,2699,2763,3905],"E3":[537,556,591,624,643,655,1068,1091,1270,3653,3685,3695,3734],"ubiquitin":[538,577,609,630,1087,1449],"ligase":[539,557,625,656,1092,1271,3654,3735,4080],"(\u201charness\u201d;":[540],"17;":[542],"Fig.":[543],"1).":[544],"Through":[545],"components,":[547],"bind":[551,918,1209,4099],"form":[559],"POI\u2013PROTAC\u2013E3":[561],"ternary":[562,1164,2204,4081],"complex,":[563,4082],"ubiquitination":[568,1189,3152],"degradation":[571,637,837,1036,1075,1134,1442,1480,1599,1656,1667,1737,1980,2080,2122,2262,2364,2392,2522,2738,2830,2839,2985,2993,3015,3252,3276,3463,4087,4108],"through":[575,1206,4090],"proteasome":[578,1457],"system":[579],"(UPS;":[580],"17).When":[582],"molecule":[585,867,890,1318,2491],"links":[586],"ligase,":[592],"stimulates":[594],"polyubiquitination":[596],"process":[597],"former":[600],"(18).":[601,638],"Specifically,":[602,1587,1853],"causes":[604],"repeated":[606],"transfer":[607,1088,1447],"ubiquitin-activating":[612],"enzyme":[613,618],"(E1)":[614],"ubiquitin-conjugating":[617],"(E2),":[619],"allows":[622],"ultimately":[627],"attach":[628],"POI,":[633,1095,1113],"marking":[634],"more":[640,1545],"than":[641,1262,2027,2693,2808],"600":[642],"ligases":[644,3696],"identified":[647,941,2507],"humans,":[649],"under":[651],"physiologic":[652],"conditions,":[653],"each":[654],"relative":[658],"specificity":[659,777,1181,1942],"towards":[660,1890],"own":[662],"set":[663],"(19).":[666,932],"Of":[667,2012],"these,":[668],"von-Hippel-Lindau":[669],"(VHL)":[670],"cereblon":[672],"(CRBN)":[673],"most":[675,1723,1841,2232,2786,3477,3492,3565],"frequently":[676],"used":[677,719,1894,2485],"development":[680,1288,4167],"due":[681,1248,1444,3589,3678,3868],"their":[683,1011,1211,1492,1503,1533,1540,2028,2193,2809,3040,4062],"ubiquitous":[684,3681],"human":[687],"tissue":[688,2281,2558],"(19,":[689,905,1123,1144,1167,1236,1272,1298],"20).":[690],"Others":[691],"include":[692,724],"murine":[693],"double":[694],"minute":[695],"2":[696,1670,2471],"(MDM2)":[697,2059],"inhibitor":[699,1547],"apoptosis":[701,801],"(IAP;":[703],"18\u201322).CRBN":[705],"direct":[708],"molecular":[709],"immunomodulatory":[712,787,3424,3524,3792,3832],"drugs":[713],"(IMiD),":[714],"some":[715,3665],"clinic":[722,1960,3078],"thalidomide,":[725],"lenalidomide,":[726],"pomalidomide":[728,1474,3925],"(23,":[729,789],"24).":[730],"Although":[731,1027,1413,1719],"CRBN":[732,743,3659,3944],"targets":[733,1046],"endogenous":[735],"substrates,":[736],"neosubstrates":[738],"(i.e.,":[739,923,963,1052,4109],"substrates":[740],"recognized":[741],"only":[744,1175,1428,1971],"presence":[747,1712],"IMiDs)":[749],"identified,":[753],"Ikaros":[756],"Family":[757],"Zinc":[758],"Finger":[759],"1":[760,2312,3255],"(IKZF1)":[761],"3":[763,1430,3233,3319,3495,3579],"(IKZF3;":[764],"23,":[766],"25,":[767],"26).":[768],"redirection":[773],"CRBN's":[775],"IKZF1":[780,1590,2998,3154,3275,3870],"IKZF3":[782,1578,1592,2248,3000,3872],"elicits":[783],"antitumor":[785],"effects":[788,828,904,1952,2849,2865,3677,3864],"27\u201335).":[790],"Briefly,":[791],"IMiDs":[792,830,3148],"shown":[795,3113,3143],"inhibit":[797],"induce":[800,4074,4107],"favorably":[806],"modulate":[807],"T":[808,3160,3818],"repair":[811],"immunologic":[813],"synapse":[814],"vitro":[817,1623,3122,4067],"vivo":[820,2280,2570,2701,4070],"(27\u201335).":[821],"These":[822,2572,4072],"suggest":[824],"pharmacological":[827],"due,":[832],"part,":[834],"neosubstrates,":[840],"hence":[842],"effect":[844,2209,3765],"may":[845,1936,1948,3655,3660,3673,3727,3799,3962],"contribute":[846],"activity":[849,1001,1229,1957,2678,3145,3271,3525],"CRBN-based":[851],"PROTACs":[852,860,877,911,992,1023,1028,1218,1246,1304,1336,1348,1376,1402,1422,1440,1496,1639,1728,1755,1784,2040,2049,2063,2179,2291,2414,2499,2756,2768,3053,3075,3092,3672,3795,3961,4073,4094,4132],"(23).The":[853],"unique":[854],"mechanism":[855],"action":[857],"employed":[858,1142],"sets":[861],"them":[862],"apart":[863],"conventional":[865],"inhibitors.":[868,1323],"review":[872,1325,1352],"Madan":[874],"colleagues,":[876],"operate":[881,1029],"catalytic":[884,1032,4086],"manner,":[885,1033],"meaning":[886],"single":[888,2468,2582],"proteins,":[895],"potentially":[896,3688],"allowing":[897,4083],"lower":[899],"concentrations":[900,1882,2128,2254,2323,2989],"less":[902,2025],"off-target":[903,1956],"36).":[906],"contrast":[908,1625],"POIs":[914],"without":[915,3523],"having":[916],"active":[921,2041,4102],"site":[922,4103],"ATP-binding),":[924],"substantially":[925],"broadening":[926],"scope":[928],"targetable":[930],"As":[933,2216,3691],"we":[934,3910],"mentioned":[935],"above,":[936],"amongst":[942],"(13,14).":[947],"Some":[948],"mutations,":[951],"BTKV416L":[954],"BTKL528W,":[956],"known":[958,1220],"lack":[960],"function":[962,989,1007,3833,3838],"phosphorylation)":[965],"but":[966,1182,1989,2089,2746,3499,3607],"still":[967],"facilitate":[968],"(37).":[972,990],"suggests":[974,3648],"\u201ckinase":[977],"dead\u201d":[978],"mutants":[980],"confer":[981,3661],"maintaining":[986],"scaffolding":[988,1006],"Thus,":[991,3956,4158],"potential":[995,3860,3993],"well":[1003,1691,2297,2399,2548,2686,3474],"underscoring":[1010],"applicability":[1012],"malignancies.Despite":[1016],"advantages,":[1018],"effective":[1020],"design":[1021,1125,2168,2478],"warrants":[1024],"careful":[1025],"consideration.":[1026],"efficiency":[1037,1076,1085,1796],"solely":[1040],"determined":[1041,1899],"quantity":[1044],"engaged":[1049],"degraded":[1051,1103,1574,1589,1786,1856,2092,2273,2339,2352,2530,2715,2946],"dependent":[1056],"affinities":[1059],"ligands":[1062,1212,1407,1646,2761],"either":[1064,1266,2694,3134],"or":[1067,1269,1453,1494,1713,2052,2057,2696,2723,3136,3814,3835,3881],"ligase;":[1069],"19,":[1071],"38).":[1072,1145,1168],"Instead,":[1073],"multitude":[1080],"factors,":[1082,3850],"rate":[1097,1116],"proteasome,":[1106],"basal":[1108],"level":[1110],"replenished":[1122],"38\u201341).One":[1124],"aspect":[1126],"should":[1128,3777,4031],"be":[1129,1354,1391,2024,2851,3055,3728,3737,3755,3829,3839,3896,3912,4032],"considered":[1130],"ensure":[1132],"efficient":[1133,2511],"lies":[1135],"strategic":[1138],"selection":[1139,1147],"linker":[1143,1158,1173,2189,2199,2225],"length":[1153,1194,2200],"composition":[1155,1196],"play":[1159],"major":[1161],"complex":[1165,2205],"formation":[1166,1258,4076],"because":[1171],"PROTAC's":[1179],"POI's":[1186],"susceptibility":[1187],"(38).":[1190],"Furthermore,":[1191,1987,2362,2812,2897],"linker's":[1193],"affect":[1198],"PROTACs\u2019":[1200],"overall":[1201],"conformation":[1202],"orientation":[1205],"they":[1208,2195,4030],"(19).Another":[1213],"intrinsic":[1214],"challenge":[1215],"faced":[1216],"\u201chook":[1223,1875],"effect,\u201d":[1224],"characterized":[1225],"concentration-dependent":[1228],"curve":[1230],"follows":[1232],"bell-shaped":[1234],"pattern":[1235],"42).":[1237,1273],"To":[1238,1378,2861],"elaborate,":[1239],"higher":[1241,3662],"concentrations,":[1242,1489],"effectiveness":[1244],"diminishes":[1247],"saturation":[1251],"binding":[1253,1387,1914,4111],"sites":[1254],"favor":[1256],"binary,":[1260],"rather":[1261],"ternary,":[1263],"complexes":[1264],"This,":[1274],"turn,":[1276],"renders":[1277],"resistant":[1280],"degradation,":[1282],"obstacle":[1285],"optimization,":[1290,2169,2427],"especially":[1291],"dosing":[1296],"strategies":[1297],"42).With":[1299],"aspects":[1301],"mind,":[1303],"present":[1305],"exciting":[1307],"new":[1308],"strategy":[1310],"overcome":[1312],"limitations":[1313],"traditional":[1316],"cancer":[1319],"therapies,":[1320,3809,4002],"will":[1326,3736,3752,3836,3846],"now":[1327],"groups":[1331,3049,4060],"focused":[1332],"developing":[1334],"BTK-targeted":[1335,1375,1561,1638,1754,1834,2039,2178,2290,2498,2647,2767,3052,3091,4056,4131,4169],"treatment":[1339,1804,1818,2374,2609,2707,2720,2817,4139],"lymphoid":[1341,3104],"malignancies.":[1342,3105,4157],"comprehensive":[1344],"list":[1345],"discussed":[1349,3640,3716],"found":[1355,1538,2022,2237,2780,2815,2879],"Table":[1357],"1.In":[1358],"2019,":[1359],"Tinworth":[1360],"colleagues":[1362,1463,1499,1557,1631,1746,1829,2034,2172,2285,2408,2484,2651,2751,2912],"were":[1363,1411,1676,1747,2021,2338,2465,2574,3037,3292,3304,3322,3343,3401,3437,3501,3505,3563,3581,3593,3609,4204],"first":[1365,1749],"evaluate":[1367],"differences":[1369],"between":[1370],"(irreversible)":[1372,1730],"covalent-reversible":[1374,1380,1419,1467,1504,1560,1637],"(43).":[1377],"generate":[1379],"PROTACs,":[1381,1535,1835,2019,2481,2648,4057],"authors":[1383,1537,1893,2132,2779,2814,2870],"selected":[1384,2229],"moieties":[1388],"could":[1390,2850,3054],"altered":[1392,1938],"maintain":[1394],"reversible":[1395,2418],"binding.":[1397],"study,":[1400],"IAP-based":[1401],"containing":[1403,2180,2757],"covalent-irreversible-":[1404],"covalent-reversible-based":[1406],"derived":[1408],"compared.":[1412],"covalent-irreversible":[1415,1439,1493],"(PROTAC":[1416,1420],"2)":[1417],"3)":[1421],"inhibited":[1423,1694,2430,2624,3017],"THP1":[1426],"resulted":[1431,1810,2258,2727,2827],"degradation.":[1434,3873],"It":[1435],"was":[1436,1517,1543,1721,1839,1877,2228,2236,2371,2461,2506,2547,2566,2602,2630,2784,2805,2994,3112,3272,3332,3383,3464,3473,3490,3604],"suggested":[1437],"lost":[1441],"capabilities":[1443],"onto":[1450],"access":[1454],"being":[1458,2211,2272,3528,3702],"blocked":[1459,2355],"(43).Similarly,":[1460],"Guo":[1461],"concluded":[1464],"PROTAC,":[1468,1505,1562,1650,1725,2072],"RC-1,":[1469],"contained":[1471,1509,1641,1844,2050,2115],"ibrutinib-":[1472,2051,2069],"(CRBN)-based":[1475,1645,2118],"ligands,":[1476,1571,2504],"exhibited":[1477,1978,2556,3369],"potent":[1478,1546,1724,2026,2233,2787,2963],"BTKWT":[1479,2044,2335,2394,2435,2940,2967,3117],"MOLM-14":[1482,1789],"8":[1485,2527,2842,3468],"40":[1487],"nmol/L":[1488,1621,1741,1800,1865,2328,2443,2516,2673,2797,2823],"compared":[1490,1531,1816,1943],"(41).Xue":[1497],"showed":[1501,2064],"\u201ccompound":[1506,2219,2428,2782],"7,\u201d":[1507],"ibrutinib-based":[1511,1642,1846,2501,2758],"hook":[1512,1762,1773,1847,2295,2424,2933],"VHL-based":[1515,2018,3671],"harness,":[1516,2186],"able":[1518,3886],"significantly":[1520],"reduce":[1521],"K562":[1524],"18":[1526],"hours":[1527,1867,2331,2857],"post-treatment":[1528,1868],"(44).":[1529],"When":[1530],"against":[1532,1975,2042,2679],"better":[1549,2807],"degrader":[1550,2789,3419,3522,3619,3827],"(44).In":[1553],"Yu":[1555],"developed":[1558,3056],"another":[1559,3616],"PS-2,":[1563],"using":[1564],"poseltinib-based":[1565],"(an":[1566],"irreversible":[1567],"BTKi)":[1568],"pomalidomide-based":[1570,1781,1850,2029,2071,2185,2413,2760],"potently":[1573,2351],"IKZF1,":[1576,2246],"Mino,":[1580],"RAMOS,":[1581],"A20":[1582],"HEK-293":[1584],"(45).":[1586],"PS-2":[1588],"Mino":[1594,1610,1659,2358,2524,2801],"half-maximal":[1598,1615],"concentration":[1600,1617,1860,2314],"(D50)":[1601],"27.8":[1603],"2.5":[1605],"nmol/L,":[1606,2954,2976],"respectively,":[1607,2803,2977],"reduced":[1609,1993,2316,2591],"growth":[1612,2431,2626],"inhibitory":[1616],"(IC50)":[1618],"77":[1620],"(45).In":[1624],"findings,":[1628],"Gabizon":[1629],"explored":[1633,3703,3756,3918],"noncovalent,":[1634],"covalent-irreversible,":[1635],"thalidomide":[1644],"(46).":[1647,1683],"The":[1648,3219,3285,3363,3841,3936],"NC-1,":[1651],"demonstrated":[1652,2133,3050,3553],"highest":[1654,2066,2076],"potency":[1657,1974,3663],"(DC50":[1661],"=":[1662],"2.2":[1663],"nmol/L),":[1664],"maximum":[1666],"occurring":[1668,2840],"4":[1672,1792,1866,2330,2672,2834],"hours.":[1673,2528,2607,2843],"Similar":[1674,2458,3035],"trends":[1675],"primary":[1679,1997,2958],"patient":[1681],"samples":[1682,1999],"Treatment":[1684,2148,2251,3244,3472,3587],"NC-1":[1686,1720],"abolished":[1687],"partially":[1693],"ERK,":[1698],"PLC\u03b32":[1700],"restricted":[1702],"activation,":[1705],"viability,":[1706],"migration":[1708],"regardless":[1709],"absence":[1714],"(47).":[1718],"IR-2":[1729],"RC-3":[1732],"(reversible)":[1733],"induced":[1735,2121,2151,2519,2962,3013],"DC50\u2019s":[1739,2971],"<10":[1740],"(46).In":[1742],"2018,":[1743],"Huang":[1744],"group":[1750,2015],"develop":[1752],"(48).":[1756],"CJH-005\u2013067":[1757],"consisted":[1758,1769],"bosutinib-based":[1761],"(targets":[1763],"BCR-ABL":[1764],"BTK),":[1766,4119],"DD-04\u2013015":[1768,1809],"RN486-based":[1772],"(a":[1774,2417],"selective":[1775,2513,3617],"BTKi),":[1776],"integrating":[1779],"harness.":[1782],"Both":[1783,2334],"effectively":[1785,1992,2590],"hours,":[1793,2600,2835],"peak":[1795],"100":[1799,2327,2588,2822,3212],"concentration.":[1801],"TMD8":[1806,2343,2702,2943],"decreased":[1812,3260],"viability":[1814],"RN486":[1820],"(control;":[1821],"48).Building":[1823],"upon":[1824],"momentum,":[1826],"Buhimschi":[1827],"generated":[1830,2017,2035,2652,2752],"array":[1832],"MT-802":[1838,1854,1903,1911,1947,1966,1972,2810],"potent,":[1842],"harness":[1851,2119,2301,2665,2937],"(49).":[1852,1986],"fully":[1855],"low":[1862,1888,2126,2325],"250":[1864],"Namalwa":[1870],"cells.":[1871,2344,2361],"effect\u201d":[1876],"compound":[1881,2256,2447,2474,2825,2867,2876,2898,2917],"\u22642.5":[1883],"\u03bcmol/L.":[1884],"Because":[1885],"selectivity":[1889,2403],"KINOMEscan":[1896],"assay":[1897],"although":[1901,1964],"strongly":[1906],"bound":[1907,2308],"TEC,":[1910],"displayed":[1912],"weaker":[1913],"other":[1916,2138,3103,3790,4155,4208],"kinases,":[1917],"IL-2-inducible":[1919],"T-cell":[1920],"(ITK),":[1922],"well-recognized":[1924],"(49,":[1927],"50).":[1928],"highlights":[1930],"feature":[1932],"degraders":[1935,3639,3744,3780,3895,3970,3996,4021],"improved":[1940],"BTKi's,":[1945],"fewer":[1950],"side":[1951,3863],"mediated":[1953],"ibrutinib's":[1955],"(10,":[1961],"49).":[1962],"Importantly,":[1963,3399],"targeted":[1969],"BTKWT,":[1970],"maintained":[1973,2852],"similar":[1979,3146],"kinetics":[1981],"variants":[1985,2397],"MT-802,":[1988],"levels":[1995,2077,2318,2594,2637],"who":[2002,3409,3900],"had":[2003,2668,3389,3901],"relapsed":[2004],"harbored":[2008],"mutation.":[2011],"note,":[2013],"agents":[2030],"(49).Concurrently,":[2031],"Sun":[2032],"panel":[2037],"(22).":[2047,3667],"Their":[2048],"spebrutinib-based":[2053],"hooks":[2054],"pomalidomide-":[2056],"RG-7112-based":[2058],"harnesses.":[2060],"Interestingly,":[2061],"CRBN-recruiting":[2062],"potency,":[2067],"P13I,":[2073,2088],"demonstrating":[2074,4061,4147],"Ramos":[2082,2320,2799,2819],"(73%":[2084],"10":[2086,2257,2722],"nmol/L).":[2087],"HeLa":[2096],"DLBCL":[2099,2379],"lines":[2101,3358,4036],"while":[2102,3030],"targeting":[2104,3768],"ITK.":[2105],"created":[2109,2173,2286,2409],"same":[2112],"group,":[2113],"L18I,":[2114],"lenalidomide":[2117,3923],"nanomolar":[2127],"(51).":[2129],"Moreover,":[2130],"L18I's":[2134],"ability":[2135],"clinically":[2139],"relevant":[2140,4124],"C481":[2144],"locus,":[2145],"C481T/G/W/A.":[2147],"L18I":[2150],"rapid":[2152],"tumor":[2153,2369,2625,2730,3033,3131],"regression":[2154,2731],"HBL-1":[2158],"xenograft":[2159,2383,2703,3009,3044,3130],"mouse":[2160,2384,2596,2704,2908,3010,3045,3129],"model":[2161,2490,2909,3046],"signs":[2164],"toxicity":[2166],"(51).Exploring":[2167],"Zorba":[2170],"11-compound":[2175],"library":[2176],"PF-06250112":[2182],"(BTKi)-based":[2183],"hook,":[2184],"lengths":[2190],"(52).":[2191],"From":[2192,2303]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}